EBMT TV, produced by WebsEdge/Health for European Society for Blood and Marrow Transplantation- EBMT 2019 Annual Meeting, 24-27 March in Frankfurt, Germany.
For our first day’s debate, we focus CAR-T cell therapy, newly approved in the USA and Europe, but how difficult is it to implement, and which patients will it ultimately help. Prof. Christian Chabannon (Chair, EBMT Cell Therapy & Immunobiology Working Party), Prof. Alvaro Urbano-Ispizua and Dr Silvia Montoto tell us more.
Comments:
No comments yet... Be the first!
Post your comment:
Your comment has been sent and is waiting for approval to be displayed.
Your comment cannot be sent. Please try again.
"WebsEdge was a great team to work with. They covered our 101st Annual Meeting and did a great job at capturing the message we wanted to convey to our attendees. Seemless process prior, during and after the meeting."